XML 25 R14.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Accrued Expenses
 3 Months Ended
Mar. 31, 2024
Accrued Expenses  
Accrued Expenses

Note 8. Accrued Expenses

 

Accrued expenses consisted of the following ($ in thousands):

 

 

 

March 31,

2024

 

 

December 31,

2023

 

Legal expenses

 

$69

 

 

$102

 

Offering costs

 

 

1,356

 

 

 

1,356

 

Compensation and related benefits

 

 

20

 

 

 

43

 

Other accrued expenses

 

 

195

 

 

 

232

 

Accrued expenses

 

$1,640

 

 

$1,733

 

 

The product warranty accrual related to the voluntary recall of DABRA catheters, was initiated in September 2019. The recall was closed by the FDA in July 2023 and no claims have been submitted in approximately 2 years. As such, the Company derecognized the warranty liability of $192 thousand as of December 31, 2023. As of March 31, 2024 and December 31, 2023, there is no accrued warranty balance.